Cannabis Law Update

Updates on Laws, Regulations and Trends Impacting the Cannabis Industry

Subscribe
Visit Blog
By: Kelley Drye & Warren LLP

Blog Authors

Lee Baumgardner
Sophie Berner-Eyde
Kelley Drye
Jennifer I. Fischer
Janine Fletcher-Thomas
Barbara E. Hoey
Mark A. Konkel
Constantine (Dino) Koutsoubas
Matthew C. Luzadder
Kandice M. McLeod
Jaimie Nawaday
Steven R. Nevolis
Alyssa M. Smilowitz
Bez Stern
Kristi Wolff
Laura van der Meer

Latest from Cannabis Law Update

As we discussed previously, a truck driver and his wife brought suit in New York federal court against three companies selling a CBD oil product the trucker claims caused him to fail a drug test and thereby lose his job. Back in April, the U.S. District Court Judge, Frank Geraci, dismissed several of plaintiffs’ claims, leaving only two claims for fraudulent inducement and civil RICO. As a result, plaintiffs then moved under Federal Rule…
So imagine that your biggest pothead friend from college has opened up a cannabis dispensary that sells weed for recreational use. Your old pal would be selling something that remains utterly unlawful under federal law, the recent and sweeping changes to state law notwithstanding. But two wrongs don’t make a right, according to the Tenth Circuit Court of Appeals:  if you’re going to sell something that federal law treats just like heroin, you’d at least…
On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome in patients aged two and over. The drug is the first to be approved using the centralized procedure, meaning that it is authorized to be placed on the market throughout the 28 Member States…
This week the United States House of Representatives is expected vote on the Secure and Fair Enforcement (“SAFE”) Banking Act under a special process called “suspension of the rules,” which allows for limited debate and requires a two-thirds majority to support it for passage.  The bipartisan bill would effectively protect financial institutions serving cannabis-related (defined as marijuana) businesses from federal intervention in states or Indian country that allow for the “cultivation, production, manufacture, sale, transportation,…